Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amylyx Pharmaceuticals Current Ratio 2021-2024 | AMLX

Amylyx Pharmaceuticals current ratio from 2021 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Amylyx Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-06-30 $0.33B $0.07B 4.66
2024-03-31 $0.41B $0.09B 4.48
2023-12-31 $0.47B $0.08B 5.66
2023-09-30 $0.43B $0.05B 9.52
2023-06-30 $0.43B $0.06B 6.67
2023-03-31 $0.39B $0.05B 7.54
2022-12-31 $0.38B $0.05B 8.20
2022-09-30 $0.17B $0.03B 5.28
2022-06-30 $0.22B $0.03B 7.96
2022-03-31 $0.27B $0.03B 9.58
2021-12-31 $0.11B $0.02B 6.03
2021-09-30 $0.00B 0.00
2021-06-30 $0.00B 0.00
2021-03-31 $0.00B 0.00
2020-12-31 $0.01B $0.01B 1.86
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.196B $0.381B
Amylyx Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It focuses on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $87.548B 34.88
Takeda Pharmaceutical (TAK) Japan $47.505B 9.51
Merck (MKGAF) Germany $24.427B 26.66
Astellas Pharma (ALPMY) Japan $21.987B 26.41
Sandoz Group AG (SDZNY) Switzerland $17.576B 0.00
Summit Therapeutics (SMMT) United States $16.780B 0.00
United Therapeutics (UTHR) United States $15.631B 16.15
Shionogi (SGIOY) Japan $13.344B 12.78
Neurocrine Biosciences (NBIX) United States $12.164B 36.39
Catalent (CTLT) United States $10.908B 0.00
Revolution Medicines (RVMD) United States $7.714B 0.00
Orion OYJ (ORINY) Finland $7.424B 30.23
Jazz Pharmaceuticals (JAZZ) Ireland $6.873B 7.29
Ionis Pharmaceuticals (IONS) United States $6.249B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.260B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.312B 0.00
Corcept Therapeutics (CORT) United States $4.276B 36.21
Dyne Therapeutics (DYN) United States $3.656B 0.00
PTC Therapeutics (PTCT) United States $2.782B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.727B 15.73
Arrowhead Pharmaceuticals (ARWR) United States $2.628B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.534B 20.14
Soleno Therapeutics (SLNO) United States $2.050B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.951B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.796B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.686B 0.00
Xencor (XNCR) United States $1.653B 0.00
Harrow (HROW) United States $1.649B 0.00
Cassava Sciences (SAVA) United States $1.457B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.446B 0.00
ARS Pharmaceuticals (SPRY) United States $1.441B 0.00
Ardelyx (ARDX) United States $1.410B 0.00
Ocular Therapeutix (OCUL) United States $1.410B 0.00
Indivior (INDV) United States $1.335B 6.13
Avadel Pharmaceuticals (AVDL) Ireland $1.309B 0.00
Evotec AG (EVO) Germany $1.290B 0.00
Collegium Pharmaceutical (COLL) United States $1.254B 7.20
Calliditas Therapeutics AB (CALT) Sweden $1.204B 0.00
Enliven Therapeutics (ELVN) United States $1.090B 0.00
Relay Therapeutics (RLAY) United States $1.052B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.030B 0.00
Bioventus (BVS) United States $0.938B 30.50
Cronos Group (CRON) Canada $0.852B 0.00
USANA Health Sciences (USNA) United States $0.766B 14.05
Savara (SVRA) United States $0.764B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.720B 45.10
4D Molecular Therapeutics (FDMT) United States $0.702B 0.00
ProKidney (PROK) United States $0.692B 0.00
Pacira BioSciences (PCRX) United States $0.678B 6.41
Exscientia (EXAI) United Kingdom $0.629B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.623B 0.00
Siga Technologies (SIGA) United States $0.609B 7.29
Tourmaline Bio (TRML) United States $0.579B 0.00
OmniAb (OABI) United States $0.559B 0.00
Eliem Therapeutics (ELYM) United States $0.555B 0.00
Silence Therapeutics (SLN) United Kingdom $0.548B 0.00
Altimmune (ALT) United States $0.538B 0.00
Foghorn Therapeutics (FHTX) United States $0.535B 0.00
Sage Therapeutics (SAGE) United States $0.482B 0.00
KalVista Pharmaceuticals (KALV) United States $0.475B 0.00
Aquestive Therapeutics (AQST) United States $0.474B 0.00
Larimar Therapeutics (LRMR) United States $0.456B 0.00
Verve Therapeutics (VERV) United States $0.455B 0.00
Xeris Biopharma Holdings (XERS) United States $0.441B 0.00
Zevra Therapeutics (ZVRA) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.415B 38.89
Theravance Biopharma (TBPH) Cayman Islands $0.402B 0.00
Lyell Immunopharma (LYEL) United States $0.399B 0.00
Organogenesis (ORGO) United States $0.388B 0.00
Aldeyra Therapeutics (ALDX) United States $0.359B 0.00
Korro Bio (KRRO) United States $0.358B 0.00
Lexeo Therapeutics (LXEO) United States $0.345B 0.00
Esperion Therapeutics (ESPR) United States $0.343B 0.00
Heron Therapeutics (HRTX) United States $0.306B 0.00
Akebia Therapeutics (AKBA) United States $0.288B 0.00
ESSA Pharma (EPIX) Canada $0.288B 0.00
Avita Medical (RCEL) United States $0.281B 0.00
Black Diamond Therapeutics (BDTX) United States $0.270B 0.00
Nature's Sunshine Products (NATR) United States $0.257B 17.59
Nanobiotix S.A (NBTX) France $0.251B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.241B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.239B 0.00
Acrivon Therapeutics (ACRV) United States $0.235B 0.00
Nektar Therapeutics (NKTR) United States $0.234B 0.00
Pyxis Oncology (PYXS) United States $0.217B 0.00
CytoDyn (CYDY) United States $0.200B 0.00
Telomir Pharmaceuticals (TELO) United States $0.198B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
MediWound (MDWD) Israel $0.191B 0.00
Galectin Therapeutics (GALT) United States $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Context Therapeutics (CNTX) United States $0.167B 0.00
VAXART, INC (VXRT) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.157B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Century Therapeutics (IPSC) United States $0.144B 0.00
Prelude Therapeutics (PRLD) United States $0.140B 0.00
Fractyl Health (GUTS) United States $0.130B 0.00
Assertio Holdings (ASRT) United States $0.129B 22.50
Incannex Healthcare (IXHL) Australia $0.121B 0.00
OptiNose (OPTN) United States $0.120B 0.00
Regulus Therapeutics (RGLS) United States $0.112B 0.00
Relmada Therapeutics (RLMD) United States $0.106B 0.00
Journey Medical (DERM) United States $0.105B 0.00
CASI Pharmaceuticals (CASI) China $0.101B 0.00
Citius Pharmaceuticals (CTXR) United States $0.099B 0.00
Metagenomi (MGX) United States $0.098B 0.00
Karyopharm Therapeutics (KPTI) United States $0.092B 0.00
AlloVir (ALVR) United States $0.091B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.086B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.33
Vivani Medical (VANI) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Nutriband (NTRB) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
BioLineRx (BLRX) Israel $0.052B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
ProPhase Labs (PRPH) United States $0.048B 0.00
Inotiv (NOTV) United States $0.045B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
DURECT (DRRX) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
FibroGen (FGEN) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.041B 0.00
Protara Therapeutics (TARA) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.038B 0.00
Tempest Therapeutics (TPST) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.032B 0.00
Oruka Therapeutics (ORKA) United States $0.030B 0.00
VYNE Therapeutics (VYNE) United States $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Surrozen (SRZN) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
MEI Pharma (MEIP) United States $0.021B 0.73
TherapeuticsMD (TXMD) United States $0.020B 0.00
Minerva Neurosciences (NERV) United States $0.020B 0.00
Cosmos Health (COSM) United States $0.019B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
BioVie (BIVI) United States $0.018B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Talphera (TLPH) United States $0.016B 0.00
Nuvilex (PMCB) United States $0.016B 0.00
Indaptus Therapeutics (INDP) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Conduit Pharmaceuticals (CDT) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Vivos Therapeutics (VVOS) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.46
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.78